Macrophage phagocytosis of SARS-CoV-2-infected cells mediates potent plasmacytoid dendritic cell activation

Cell Mol Immunol. 2023 Jul;20(7):835-849. doi: 10.1038/s41423-023-01039-4. Epub 2023 May 30.

Abstract

Early and strong interferon type I (IFN-I) responses are usually associated with mild COVID-19 disease, whereas persistent or unregulated proinflammatory cytokine responses are associated with severe disease outcomes. Previous work suggested that monocyte-derived macrophages (MDMs) are resistant and unresponsive to SARS-CoV-2 infection. Here, we demonstrate that upon phagocytosis of SARS-CoV-2-infected cells, MDMs are activated and secrete IL-6 and TNF. Importantly, activated MDMs in turn mediate strong activation of plasmacytoid dendritic cells (pDCs), leading to the secretion of high levels of IFN-α and TNF. Furthermore, pDC activation promoted IL-6 production by MDMs. This kind of pDC activation was dependent on direct integrin-mediated cell‒cell contacts and involved stimulation of the TLR7 and STING signaling pathways. Overall, the present study describes a novel and potent pathway of pDC activation that is linked to the macrophage-mediated clearance of infected cells. These findings suggest that a high infection rate by SARS-CoV-2 may lead to exaggerated cytokine responses, which may contribute to tissue damage and severe disease.

Keywords: Inflammatory cytokines; Interferon-α; Monocyte-derived macrophages; Plasmacytoid dendritic cell; SARS-CoV-2; COVID-19.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • COVID-19* / metabolism
  • Cytokines / metabolism
  • Dendritic Cells / metabolism
  • Humans
  • Interferon Type I* / metabolism
  • Interferon-alpha / metabolism
  • Interleukin-6 / metabolism
  • Macrophages / metabolism
  • Phagocytosis
  • SARS-CoV-2 / metabolism

Substances

  • Interleukin-6
  • Interferon-alpha
  • Cytokines
  • Interferon Type I